Literature DB >> 22806157

Inhibition of H. pylori colonization and prevention of gastritis in murine model.

Mahdieh Ameri Shah Reza1, Seyed Latif Mousavi Gargari, Iraj Rasooli, Mohammadreza Jalali Nadoushan, Walead Ebrahimizadeh.   

Abstract

Helicobacter pylori is a Gram-negative spiral bacterium that colonizes human gastric mucosa causing infection. In this study aiming at inhibition of H. pylori infection we made an attempt to evaluate immunogenicity of the total (UreC) and C-terminal (UreCc) fragments of H. pylori urease. Total UreC and its C-terminal fragment were expressed in E. coli. Recombinant proteins were analyzed by SDS-PAGE and western blot and then purified by Ni-NTA affinity chromatography. Female C57BL6/j mice were immunized with the purified proteins (UreC and UreCc). Antibody titers from isolated sera were measured by ELISA. Immunized mice were then challenged by oral gavage with live H. pylori Sydney strain SS1. Total of 109 CFU were inoculated into stomach of immunized and unimmunized healthy mice three times each at one day interval. Eight weeks after the last inoculation, the blood sample was collected and the serum antibody titer was estimated by ELISA. Stomach tissues from control and experimental animal groups were studied histopathologically. UreC and UreCc yielded recombinant proteins of 61 and 31 kDa respectively. ELIZA confirmed establishment of immunity and the antibodies produced thereby efficiently recognized H. pylori and inhibited its colonization in vivo. Pathological analysis did not reveal established infection in immunized mice challenged with H. pylori. The results support the idea that UreC and UreCc specific antibodies contribute to protection against H. pylori infections.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22806157     DOI: 10.1007/s11274-012-1059-5

Source DB:  PubMed          Journal:  World J Microbiol Biotechnol        ISSN: 0959-3993            Impact factor:   3.312


  34 in total

1.  Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report.

Authors:  P Malfertheiner; F Megraud; C O'Morain; F Bazzoli; E El-Omar; D Graham; R Hunt; T Rokkas; N Vakil; E J Kuipers
Journal:  Gut       Date:  2006-12-14       Impact factor: 23.059

2.  Comparative proteome analysis of Helicobacter pylori.

Authors:  P R Jungblut; D Bumann; G Haas; U Zimny-Arndt; P Holland; S Lamer; F Siejak; A Aebischer; T F Meyer
Journal:  Mol Microbiol       Date:  2000-05       Impact factor: 3.501

3.  Prospective multicentre study on antibiotic resistance of Helicobacter pylori strains obtained from children living in Europe.

Authors:  S Koletzko; F Richy; P Bontems; J Crone; N Kalach; M L Monteiro; F Gottrand; D Celinska-Cedro; E Roma-Giannikou; G Orderda; S Kolacek; P Urruzuno; M J Martínez-Gómez; T Casswall; M Ashorn; H Bodanszky; F Mégraud
Journal:  Gut       Date:  2006-04-07       Impact factor: 23.059

4.  Cost-effectiveness of a potential prophylactic Helicobacter pylori vaccine in the United States.

Authors:  Marcia F T Rupnow; Alicia H Chang; Ross D Shachter; Douglas K Owens; Julie Parsonnet
Journal:  J Infect Dis       Date:  2009-10-15       Impact factor: 5.226

5.  Safety and immunogenicity of an intramuscular Helicobacter pylori vaccine in noninfected volunteers: a phase I study.

Authors:  Peter Malfertheiner; Viola Schultze; Bernd Rosenkranz; Stefan H E Kaufmann; Timo Ulrichs; Deborah Novicki; Francesco Norelli; Mario Contorni; Samuele Peppoloni; Duccio Berti; Daniela Tornese; Jitendra Ganju; Emanuela Palla; Rino Rappuoli; Bruce F Scharschmidt; Giuseppe Del Giudice
Journal:  Gastroenterology       Date:  2008-05-28       Impact factor: 22.682

6.  Oral immunogenicity and protective efficacy in mice of a carrot-derived vaccine candidate expressing UreB subunit against Helicobacter pylori.

Authors:  Hongxin Zhang; Ming Liu; Yanjie Li; Yinghui Zhao; Hao He; Guodong Yang; Chengchao Zheng
Journal:  Protein Expr Purif       Date:  2009-08-03       Impact factor: 1.650

7.  Epidemiology of Helicobacter pylori infection in asymptomatic children: a prospective population-based study from the Czech Republic. Application of a monoclonal-based antigen-in-stool enzyme immunoassay.

Authors:  Josef Sýkora; Konrad Siala; Jana Varvarovská; Petr Pazdiora; Renáta Pomahacová; Michal Huml
Journal:  Helicobacter       Date:  2009-08       Impact factor: 5.753

Review 8.  Helicobacter pylori vaccine: from past to future.

Authors:  Kanishtha Agarwal; Shvetank Agarwal
Journal:  Mayo Clin Proc       Date:  2008-02       Impact factor: 7.616

9.  Role of Peyer's patches in the induction of Helicobacter pylori-induced gastritis.

Authors:  Shigenori Nagai; Hitomi Mimuro; Taketo Yamada; Yukiko Baba; Kazuyo Moro; Tomonori Nochi; Hiroshi Kiyono; Toshihiko Suzuki; Chihiro Sasakawa; Shigeo Koyasu
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-14       Impact factor: 11.205

10.  Helicobacter pylori infection in patients undergoing upper endoscopy, Republic of Georgia.

Authors:  Nato Tarkhashvili; Rusudan Beriashvili; Neli Chakvetadze; Maia Moistsrapishvili; Maia Chokheli; Merab Sikharulidze; Lile Malania; Nato Abazashvili; Ekaterine Jhorjholiani; Marina Chubinidze; Nanuli Ninashvili; Tamar Zardiashvili; Ucha Gabunia; Dimitri Kordzaia; Paata Imnadze; Jeremy Sobel; Jeannette Guarner
Journal:  Emerg Infect Dis       Date:  2009-03       Impact factor: 6.883

View more
  1 in total

Review 1.  Oral passive IgY-based immunotherapeutics: a novel solution for prevention and treatment of alimentary tract diseases.

Authors:  Shofiqur Rahman; Sa Van Nguyen; Faustino C Icatlo; Kouji Umeda; Yoshikatsu Kodama
Journal:  Hum Vaccin Immunother       Date:  2013-01-14       Impact factor: 3.452

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.